ES2052065T3 - Formulacion dispersable. - Google Patents

Formulacion dispersable.

Info

Publication number
ES2052065T3
ES2052065T3 ES89810772T ES89810772T ES2052065T3 ES 2052065 T3 ES2052065 T3 ES 2052065T3 ES 89810772 T ES89810772 T ES 89810772T ES 89810772 T ES89810772 T ES 89810772T ES 2052065 T3 ES2052065 T3 ES 2052065T3
Authority
ES
Spain
Prior art keywords
dispersible formulation
dispersible
formulation
disintegrant
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89810772T
Other languages
English (en)
Inventor
Lorraine Mary Murphy
Graham Paul Matthews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2052065T3 publication Critical patent/ES2052065T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

LA INVENCION PROVEE UNA FORMULACION DE DROGA SOLIDA DISPERSABLE COMPRENDIENDO DICLOROMETANO FINAMENTE DIVIDIDO COMO ACIDO LIBRE, DE 5 A 25% DE PESO DE UN DESINTEGRANTE Y UN DILUYENTE FARMACEUTICAMENTE ACEPTABLE.
ES89810772T 1988-10-18 1989-10-10 Formulacion dispersable. Expired - Lifetime ES2052065T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888824392A GB8824392D0 (en) 1988-10-18 1988-10-18 Dispersible formulation

Publications (1)

Publication Number Publication Date
ES2052065T3 true ES2052065T3 (es) 1994-07-01

Family

ID=10645384

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89810772T Expired - Lifetime ES2052065T3 (es) 1988-10-18 1989-10-10 Formulacion dispersable.

Country Status (19)

Country Link
EP (1) EP0365480B1 (es)
JP (1) JP2795924B2 (es)
KR (1) KR0151131B1 (es)
AT (1) ATE79538T1 (es)
AU (1) AU626924B2 (es)
CA (1) CA2000763C (es)
DE (1) DE68902531T2 (es)
DK (1) DK170793B1 (es)
ES (1) ES2052065T3 (es)
FI (1) FI94925C (es)
GB (1) GB8824392D0 (es)
GR (1) GR3006304T3 (es)
IE (1) IE62557B1 (es)
IL (1) IL91949A (es)
NZ (1) NZ231023A (es)
PH (1) PH30526A (es)
PT (1) PT92002B (es)
SA (1) SA90100079B1 (es)
ZA (1) ZA897853B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US20010014340A1 (en) * 1996-06-14 2001-08-16 Motohiro Ohta Intrabuccally rapidly disintegrating tablet
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
EP0839526A3 (en) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
US6312724B1 (en) 1997-04-04 2001-11-06 Isa Odidi Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof
ES2559766T3 (es) 1998-05-18 2016-02-15 Takeda Pharmaceutical Company Limited Comprimidos disgregables en la boca
AU753241C (en) * 1998-06-11 2003-05-08 Pharmacia & Upjohn Company Tablet formation
AR019935A1 (es) 1998-07-28 2002-03-27 Takeda Pharmaceutical Preparacion solida de desintegracion rapida, uso de una hidroxipropil celulosa poco sustituida en dicha preparacion y metodo para mejorar la capacidad dedesintegracion rapida de la misma
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ728442A (en) 2004-10-21 2018-05-25 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JO3352B1 (ar) 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
TW201113266A (en) * 2009-09-02 2011-04-16 Ziopharm Oncology Inc Pharmaceutical formulations for indibulin
MX2012006240A (es) 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
EP2704689B1 (en) 2012-04-19 2018-11-28 Glatt AG Taste-masked pharmaceutical compositions containing diclofenac
DE202022100544U1 (de) 2022-01-31 2022-02-16 Ranjitsing Babasing Bayas Neue orale Streifen- oder Dünnfilmform von Diclofenac-Natrium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200178B (it) 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
CH675537A5 (es) * 1988-03-25 1990-10-15 Ciba Geigy Ag

Also Published As

Publication number Publication date
KR0151131B1 (ko) 1998-10-15
CA2000763A1 (en) 1990-04-18
AU626924B2 (en) 1992-08-13
KR900005964A (ko) 1990-05-07
JPH02164824A (ja) 1990-06-25
IL91949A (en) 1993-08-18
IE893336L (en) 1990-04-18
PT92002B (pt) 1995-06-30
FI94925B (fi) 1995-08-15
GR3006304T3 (es) 1993-06-21
SA90100079B1 (ar) 1999-03-21
ATE79538T1 (de) 1992-09-15
GB8824392D0 (en) 1988-11-23
DK170793B1 (da) 1996-01-22
DE68902531T2 (de) 1993-04-08
ZA897853B (en) 1992-07-29
EP0365480A1 (en) 1990-04-25
CA2000763C (en) 2000-11-14
FI94925C (fi) 1995-11-27
IL91949A0 (en) 1990-06-10
NZ231023A (en) 1991-09-25
AU4297089A (en) 1990-04-26
EP0365480B1 (en) 1992-08-19
DK515489D0 (da) 1989-10-17
DE68902531D1 (de) 1992-09-24
DK515489A (da) 1990-04-19
FI894899A0 (fi) 1989-10-16
IE62557B1 (en) 1995-02-08
JP2795924B2 (ja) 1998-09-10
PH30526A (en) 1997-06-13
PT92002A (pt) 1990-04-30

Similar Documents

Publication Publication Date Title
ES2052065T3 (es) Formulacion dispersable.
FI935675A0 (fi) Pyrazolopyrimidiner
ZA928170B (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
TW273550B (es)
NO924172D0 (no) Substituerte bifenylpyridoner
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
ES2074462T3 (es) Derivados 3-piperazinil-benzazoles antipsicoticos.
GR3004863T3 (es)
NO933521D0 (no) Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreester samt deres pyridin-n-oksyder, fremgangsmaater for deres fremstilling og deres anvendelse som legemiddel
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
IL87867A (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-3-phenyl-azo-pyridine derivative
NO950842L (no) Diarylpiperazinoacetamidforbindelser som antimuskariniske midler
EP0987022A4 (en) PREVENTIVE AND HEALING MEDICINES FOR ULCERATIVE KOLITIS AND / OR MORBUS CROHN
ZA968315B (en) Administration by inhalation of 2-amino-6n-propyl-amino-4,5,,7-tetrahydrobenzothiazole particularly the (-)-enan-tiomer thereof and the pharmacologically acceptable acid addition salts thereof
GR3031360T3 (en) Composition based on ibuprofen, for oral usage
ITMI911842A1 (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITMI911713A1 (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 365480

Country of ref document: ES